Caitlyn Krebs is the Co-Founder & CEO at Nahlu Bio, a biopharmaceutical firm focused on designing synthetic CBD. Established in 2019, Nahlu Bio's proprietary platform is unique in that their CBD is not hemp-based, but instead uses known chemistries and existing materials to produce high-quality, low-cost, and predictable ingredients. Caitlyn talks about the benefits of synthetic CBD and the controversy.